{"SPADE_UN_17667": {"Clinical Information": [], "Patent Information": [{"Patent No": "US20020086420A1", "Patent Link": "http://www.lens.org/lens/patent/US20020086420A1", "Patent Type": "Patent Application", "Publication Date": "2002-7-4", "Family Info": "Notavailable", "Patent Title": "Novel antiangiogenic peptides", "Abstract": "The present invention provides an antiangiogenic polypeptide having the amino acid sequence set forth in SEQ ID NO: 1 or a portion thereof which is effective to inhibit endothelial cell proliferation as determined by the capillary EC proliferation assay. Preferably, the portion has at least 50% inhibition of bFGF-stimulated EC proliferation at 5 Tg/ml, more preferably 75% inhibition, most preferably 95% inhibition."}], "Sequence Information": {"SPADE ID": "SPADE_UN_17667", "Sequence": "AWYRGAAPPKQEFLDIEDP", "Sequence Length": 19, "Peptide Name": "aa 176-194", "Source": "Synthetic", "Biological Activity": ["Antimicrobial", "Anticancer"], "Frequent Amino Acids": "APD", "Absent Amino Acids": "CHMNOSTUV", "Basic Residues": 2, "Acidic Residues": 4, "Hydrophobic Residues": 11, "Polar Residues": 7, "Positive Residues": 2, "Negative Residues": 4, "Mass": 2203.41, "PI": 4.32, "Net Charge": -2, "Hydrophobicity": -0.88, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_21299", "Similarity": 0.75, "Sequence": "RWYRRWYRRWYR"}, {"SPADE_ID": "SPADE_N_13787", "Similarity": 0.5555555555555556, "Sequence": "ETKWDIEDPGKLKIQHSGTIFNNGGHKLDGEAYGSKSLVDRRDPAVFGGKLDYNHNSGSSLSVSAQHKEHRGTRVGVEGKYYLYRNGPFHADVSGKYDRTYGGASSNPSFSTHLTGTVDF"}, {"SPADE_ID": "SPADE_UN_01029", "Similarity": 0.5, "Sequence": "KKAAAGAAAAAGAAWAAGAAAKKKK"}]}}}